AIR:EURONEXT PARISAirbus SE Analysis
Data as of 2026-03-09 - not real-time
$107.87
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
AAR Corp. (AIR) is trading at $107.87, comfortably above its 50‑day and 200‑day simple moving averages of $105.36 and $83.94, signaling a sustained bullish bias. However, the price sits just below the 20‑day SMA of $114.88, indicating a short‑term pull‑back potential. The 14‑day RSI at 42.4 is in neutral territory, not yet oversold nor overbought. MACD shows a bearish divergence, with the histogram at –1.70 and the signal line above the MACD line, suggesting momentum could turn lower in the near term. Volume is increasing, supporting the current price stability and providing a cushion for downside moves toward the identified support at $102.46. On the upside, the resistance at $121.64 aligns with the 52‑week high, offering a clear target if buying pressure resumes.
Fundamentally, the company posted 15.9% revenue growth and a forward EPS of $5.50, translating to a forward P/E of 19.6, well below the trailing P/E of 42.1 and the industry average of 29.5, implying a valuation gap that could close. The balance sheet shows $1.04 bn of debt versus $75.6 m of cash, yielding a debt‑to‑equity of 66.9%, which raises leverage concerns. Operating margins are modest at 8.5% and free cash flow is modest relative to earnings, limiting immediate dividend capacity (the stock pays no dividend). The stock’s beta of 1.25 and 30‑day volatility of 33.9% point to higher systematic risk, consistent with the “Extreme Greed” sentiment index reading of 75.9. Nonetheless, the upside/downside estimate of +11% and analyst consensus of a “strong buy” with a median target of $121 reinforce a medium‑term upside narrative. In summary, the technical picture is cautiously bullish, the valuation appears fair to attractive on a forward basis, but leverage and volatility temper enthusiasm.
Fundamentally, the company posted 15.9% revenue growth and a forward EPS of $5.50, translating to a forward P/E of 19.6, well below the trailing P/E of 42.1 and the industry average of 29.5, implying a valuation gap that could close. The balance sheet shows $1.04 bn of debt versus $75.6 m of cash, yielding a debt‑to‑equity of 66.9%, which raises leverage concerns. Operating margins are modest at 8.5% and free cash flow is modest relative to earnings, limiting immediate dividend capacity (the stock pays no dividend). The stock’s beta of 1.25 and 30‑day volatility of 33.9% point to higher systematic risk, consistent with the “Extreme Greed” sentiment index reading of 75.9. Nonetheless, the upside/downside estimate of +11% and analyst consensus of a “strong buy” with a median target of $121 reinforce a medium‑term upside narrative. In summary, the technical picture is cautiously bullish, the valuation appears fair to attractive on a forward basis, but leverage and volatility temper enthusiasm.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price near short‑term resistance below 20‑day SMA
- bearish MACD divergence
- increasing volume supports current level
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- forward P/E of 19.6 indicates valuation upside
- revenue growth of 16% and positive earnings outlook
- technical support at $102.46 with upside to $121 target
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- high leverage with debt‑to‑equity 66.9%
- modest cash flow limits dividend and reinvestment
- defense and aerospace demand provides stable long‑term tailwinds
Key Metrics & Analysis
Financial Health
Revenue Growth15.90%
Profit Margin3.17%
P/E Ratio42.1
ROE6.86%
ROA5.59%
Debt/Equity66.89
P/B Ratio2.7
Op. Cash Flow$1.4M
Free Cash Flow$27.1M
Industry P/E29.5
Technical Analysis
TrendBullish
RSI42.4
Support$102.46
Resistance$121.64
MA 20$114.88
MA 50$105.36
MA 200$83.94
MACDBearish
VolumeIncreasing
Fear & Greed Index75.89
Valuation
Target Price$119.80
Upside/Downside11.06%
GradeFair
TypeGrowth
Risk Assessment
Beta1.25
Volatility33.91%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.